{"name":"Nerissa T. Viola","slug":"nerissa-t-viola","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE81LU1tM3JENUZLR0V1U0FjbTBORWh3WlN0aWh0YUpCNndnQm1UVmIxaFlEVmswRHN0SHBLUDMwWldVaWFqTzFLOUlseDhQZmpoRnFfTlJrUnEyUQ?oc=5","date":"2023-11-02","type":"pipeline","source":"jnm.snmjournals.org","summary":"Imaging Agents for PET of Inflammatory Bowel Disease: A Review - jnm.snmjournals.org","headline":"Imaging Agents for PET of Inflammatory Bowel Disease: A Review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE40Qnp3OFFnci0xa211NlBQRnJqNlpwLVhZekVQSFFYVlhPeHRfSFBPaVpYdmE4bnVtVDVyN1BqbU5Ca1JiaV9DZFBBeWwydFJpZ2hQajZLWXJnRTdmd3hF?oc=5","date":"2019-08-22","type":"pipeline","source":"Nature","summary":"Systemically Administered Plant Recombinant Holo-Intrinsic Factor Targets the Liver and is not Affected by Endogenous B12 levels - Nature","headline":"Systemically Administered Plant Recombinant Holo-Intrinsic Factor Targets the Liver and is not Affected by Endogenous B1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE0xa3pNZ1BpZll4YS1UdzFnZTRCMlFCZldvVGF1Mjh6Nko1S0hERkVwdllTRUZycFQwV0xEdVJWZlE1aWxyRnlOTkoyazRuck9tWFUyQXAyVFd6MkRDb3Fr?oc=5","date":"2018-06-13","type":"regulatory","source":"Nature","summary":"Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab) | Scientific Reports - Nature","headline":"Imaging EGFR and HER3 through 89Zr-labeled MEHD7945A (Duligotuzumab) | Scientific Reports","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}